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Knowledge of the epidemiology of pneumococcal disease in Bolivia is sparse, and Multilocus Sequence Typing (MLST) of isolates
has not been previously possible. Beni state has until recently been a geographically isolated region of the Bolivian Amazon basin
and is a region of signiﬁcant poverty. During June and July 2007, we performed a pneumococcal carriage study recruiting over 600
schoolchildrenintwotownsintheBenistate.Here,wedescribetheuniqueidentiﬁcation ofsimultaneousnasopharyngeal carriage
of two pneumococcal multilocus sequence types with a serotype 3 phenotype within a single subject.
1.Introduction
Multilocus sequence typing (MLST) is an internationally
utilized method for the molecular categorization of Strep-
tococcus pneumoniae (the pneumococcus) [1]. Pneumococci
predominantly colonise the human nasopharynx and in the
vast majority of instances do not progress to cause invasive
disease. In the ﬁrst two years of life, 95% of children can
be colonized with pneumococci and 73% can acquire at
least two diﬀerent serotypes, although these are carried on
diﬀerent occasions. Data relating to multiple colonisation is
limited; however, the range of multiple colonisation when
studied can vary dramatically from 1.3% to 30%. It is
important to note that a number of diﬀerent factors could
inﬂuence this, including, geographical locations, social and
economic factors, and sample technique [2–4]. Nasopharyn-
geal colonization can begin as early as the day of birth. The
duration of carriage for a particular serotype is commonly
2.5to4.5months,andthedurationofcarriagedecreaseswith
each successive pneumococcal serotype. This duration of
carriage is inversely correlated with age [4] as pneumococcal
carriage declines as children grow older [5]. Although it
is well documented that multiple diﬀerent serotypes (and
consequently multiple sequence types) of pneumococci may
be carried in the nasopharynx concurrently, we are unaware
of any descriptions of multiple sequence types of the same
serotype being identiﬁed simultaneously at this site.
As part of a study of pneumococcal carriage among
schoolchildren from the Beni region of Bolivia during June
and July 2007, we performed a pneumococcal carriage study2 International Journal of Microbiology
recruiting over 600 schoolchildren in two towns in the
Beni state. Here, we describe the unique identiﬁcation of
simultaneous nasopharyngeal carriage of two pneumococcal
multilocus sequence types with a serotype 3 phenotype
within a single subject.
2.MaterialsandMethods
This study was designed in accordance with the standard
method of the WHO working group [6] and an earlier
method devised by PAHO for a Latin American con-
text http://www.paho.org/spanish/ad/ths/ev/LABS-manual-
vigilancia-serotipos.pdf {accessed 10th of October 2008}.
Dacron polyester-tipped swabs (Medical Wire and Equip-
ment, UK) were couriered from the United Kingdom
for nasopharyngeal swabbing as were Skim Milk Tryp-
tone Glucose Glycerin (STGG) broth media [7]w h i c h
had been manufactured, sterilized, and quality controlled
as 1ml aliquots at the Scottish Haemophilus, Legionella,
Meningococcal, and Pneumococcal Reference Laboratory
(SHLMPRL) in cryotubes (Sarstedt AG & Co., Germany) to
be used as a short-term transport media and storage media
at −20◦C.
Five percent horse blood agar (E & O Media Ser-
vices Limited, United Kingdom) was couriered from the
United Kingdom as were optochin discs (Oxoid, United
Kingdom) and Transwabs (TSCswabs, United Kingdom).
The use of 5% horse blood rather than blood agar with
gentamicin [8], colistin-nalidixic acid, or colistin-oxolinic
acid was a necessary deviation from the published standard
method [6].
Nasopharyngeal swabs were taken by an experienced
otolaryngologist (Dr. Santana-Hernandez). If nasopharyn-
geal swabbing was not tolerated or not possible in younger
children, oropharyngeal swabs were performed. The tips of
the swabs were then cut oﬀ and stored in STGG and either
plated onto 5% horse blood agar on the same day or stored
at −20◦C until cultured. After incubation, alpha haemolytic
colonies were subcultured onto 5% horse blood agar for
optochin susceptibility testing. Incubation was performed at
37◦C in a carbon dioxide-enriched atmosphere using candle
jars at Laboratorios Altstadt, Trinidad, Bolivia.
Pure cultures of presumed pneumococci were stored at
room temperature on Transwabs (TSCswabs, United King-
dom) until ready for transportation to SHLMPRL by air [9].
Facilities for serotyping in Latin America are sparse
[10], and it is not possible to perform MLST in Bolivia.
Transportation of isolates from Trinidad, Bolivia to Glasgow,
United Kingdom took 42 days on Transwabs under condi-
tions which were not environmentally controlled.
Bloodagarwithneomycin(Oxoid,UnitedKingdom)was
used at SHLMPRL to culture isolates received on Transwabs
for 48 hours under anaerobic conditions. Isolates which
had survived transportation were further subcultured on 5%
horse blood agar and stored at −80◦ on Protect beads (TSC
Ltd, United Kingdom).
Thewholeprocessofserotypingofstrainswasperformed
at SHLMPRL using a coagglutination method [11] utilising
sera from Statens Serum Institut, Denmark.
MLST was performed on these isolates as described
previously [12–14]. Brieﬂy, fragments from the seven house-
keeping genes, aroE, gdh, gki, recP, spi, xpt, and ddl were
ampliﬁed from the pneumococcal lysate with the primers
described by Enright and Spratt [13] by using a single
PCR reaction. The ampliﬁed DNA was cleaned as previously
described [12, 15]. The cleaned ampliﬁed DNA was then
sequenced with the same primer set using the DYEnamic
ET Terminator sequencing kit (Amersham Biosciences, Little
Chalfont, United Kingdom). The subsequent sequenced
DNA was cleaned as previously described [12, 15]. These
procedures were carried out on a liquid handling robotic
platform (MWG-Biotech, Milton Keynes, United Kingdom)
and a MegaBACE 1000 DNA sequencer (Amersham Bio-
sciences). The analysis of the sequence data and the subse-
quent assignment of a sequence type (ST) were performed as
described previously [16]. Further analysis of relationships
between this and other pneumococcal STs was performed
using the BURST (Based Upon Related Sequence Types)
program [17].
3. Results
This pneumococcal carriage study was conducted among
schoolchildren from the Beni region of Bolivia, and during
this study we identiﬁed a 9-year-old girl with mucoid
pneumococci present in the nasopharynx. Colonies of this
single mucoid phenotype consistently were identiﬁed as
serotype 3 using a coagglutination method [11]. MLST was
performed on two separate colonies which were indistin-
guishable morphologically and identiﬁed one as Sequence
Type 180 (ST180) and the other as ST1989. These sequence
types diﬀer by two of the seven housekeeping genes used
in the MLST scheme. Sequence Type 1989 (ST1989) and
ST180 exist as double-locus variants within the same clonal
complex. ST1989 may possibly have arisen from ST2311
which may have arisen from ST180. The single-nucleotide
polymorphisms (SNPs) in the xpt and gdh alleles account for
these diﬀerences in sequence type.
4. Discussion
Serotype 3 pneumococci are morphologically distinct from
most other serotypes of pneumococci due to their mucoid
capsule [18]. It has been determined that duplications in the
cap3A gene in the type 3 capsule locus are associated with
high-frequencyphasevariation[19]whichrelatestocapsular
and acapsular (rough) phase variants [20].
This mucoid serotype is also a common cause of acute
otitis media [20, 21], particularly ST180 [22], where bio-
ﬁlm formation may be important in the pathogenesis of
this manifestation. Also, Serotype 3 pneumococci cause
acute conjunctivitis, and it is postulated that this serotype
possesses virulence factors which predispose it to mucosal
sites [21]. In addition, Serotype 3 is associated with an
increased relative risk of death from invasive pneumococcal
disease in Swedish adults [23], but in children, Serotype 3
ST180 pneumococci have been identiﬁed as having odds of
invasiveness of only 0.1 which was signiﬁcantly associatedInternational Journal of Microbiology 3
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Figure 1:Alignmentofsequencesforallelesxpt andgdhforST1989andST180demonstratingoneSNPdiﬀerenceinthexpt geneatposition
100 and six SNP diﬀerences in the gdh gene at positions 19, 73, 235, 361, 370, and 406.
with asymptomatic carriage [24]. Due to the limited data,
the odds ratio of the newly identiﬁed ST-1989 is unknown.
The dichotomy that Serotype 3 pneumococci can cause
disease with a high associated mortality in some individuals
while being harmlessly carried in the nasopharynx of others
has been recognised since the early 20th century [25]. An
association between Serotype 3 pneumococci causing disease
more commonly in the elderly than in children is also an
established observation [25]. Serotype 3 isolates of diﬀerent
genotypes may also have diﬀerent virulence in mice [26, 27].
We believe that this discovery of a population of
double locus variants expressing the Serotype 3 capsules
concurrently in a human host is suggestive of a number
of diﬀerent events. It is possible that multiple spontaneous
mutations resulting in single nucleotide polymorphisms
occur naturally within nasopharyngeal populations of pneu-
mococci which, in a natural bioﬁlm environment, may
be contributing to genetic diversity and genetic exchange
in vivo. This could result in altered interactions between
the Serotype 3 pneumococcal populations and their hosts
depending on which genotype was predominant, and it
is possible that this might inﬂuence disease manifestation
and outcome. Moreover, it is possible that these variants
diverged from a single genetic source long before acquisition
by this host and subsequent isolation and characterization.
Therefore, although these ﬁndings are valuable within the
context of such a unique geographic location and social
and economic environment, this data is limited and further
follow-up studies would be required to support any of
these ﬁndings.
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